{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:36:30Z","timestamp":1794281790723,"version":"4.9.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Recent research on the US opioid epidemic has focused on the white or total population and has largely been limited to data after 1999. However, understanding racial differences in long-term trends by opioid type may contribute to improving interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Using multiple cause of death data, we calculated age-standardized opioid mortality rates, by race and opioid type, for the US resident population from 1979 to 2015. We analyzed trends in mortality rates using joinpoint regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 1979 to 2015, the long-term trends in opioid-related mortality for Earlier data did not include ethnicity so this is incorrect. It is all black and all white residents in the US. blacks and whites went through three successive waves. In the first wave, from 1979 to the mid-1990s, the epidemic affected both populations and was driven by heroin. In the second wave, from the mid-1990s to 2010, the increase in opioid mortality was driven by natural\/semi-synthetic opioids (e.g., codeine, morphine, hydrocodone, or oxycodone) among whites, while there was no increase in mortality for blacks. In the current wave, increases in opioid mortality for both populations have been driven by heroin and synthetic opioids (e.g., fentanyl and its analogues). Heroin rates are currently increasing at 31% (95% confidence interval [CI] = 27, 35) per year for whites and 34% (95% CI = 30, 40) for blacks. Concurrently, respective synthetic opioids are increasing at 79% (95% CI = 50, 112) and 107% (95% CI = \u221215, 404) annually.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Since 1979, the nature of the opioid epidemic has shifted from heroin to prescription opioids for the white population to increasing of heroin\/synthetic deaths for both black and white populations. See video abstract at, http:\/\/links.lww.com\/EDE\/B377.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ede.0000000000000858","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T01:08:36Z","timestamp":1527728916000},"page":"707-715","source":"Crossref","is-referenced-by-count":183,"title":["Trends in Black and White Opioid Mortality in the United States, 1979\u20132015"],"prefix":"10.1097","volume":"29","author":[{"given":"Monica J.","family":"Alexander","sequence":"first","affiliation":[{"name":"Department of Demography, University of California, Berkeley, Berkeley, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew V.","family":"Kiang","sequence":"additional","affiliation":[{"name":"Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Institut national d\u2019\u00e9tudes d\u00e9mographiques, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20240220","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamapsychiatry.2017.0163","article-title":"The surge of opioid use, addiction, and overdoses responsibility and response of the US health care.","volume":"74","author":"Madras","year":"2017","journal-title":"JAMA Psychiatr"},{"key":"R5-20240220","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"issue":"3 suppl","key":"R6-20240220","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States.","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"R7-20240220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2007.64","article-title":"Trends in opioid prescribing by race\/ethnicity for patients seeking care in US emergency departments.","volume":"299","author":"Pletcher","year":"2008","journal-title":"JAMA J Am Med Assoc"},{"key":"R8-20240220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1057\/biosoc.2015.46","article-title":"White opioids: Pharmaceutical race and the war on drugs that wasn\u2019t.","volume":"12","author":"Netherland","year":"2017","journal-title":"Biosocieties"},{"key":"R9-20240220","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jpain.2009.10.002","article-title":"Racial and ethnic disparities in pain: causes and consequences of unequal care.","volume":"10","author":"Anderson","year":"2009","journal-title":"J Pain"},{"key":"R10-20240220","doi-asserted-by":"crossref","first-page":"e0159224","DOI":"10.1371\/journal.pone.0159224","article-title":"Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse.","volume":"11","author":"Singhal","year":"2016","journal-title":"PLoS One"},{"key":"R11-20240220","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/pme.12378","article-title":"The effect of cognitive load and patient race on physicians\u2019 decisions to prescribe opioids for chronic low back pain: a randomized trial.","volume":"15","author":"Burgess","year":"2014","journal-title":"Pain Med"},{"key":"R12-20240220","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s11606-013-2441-1","article-title":"Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities.","volume":"28","author":"Chapman","year":"2013","journal-title":"J Gen Intern Med"},{"key":"R13-20240220","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use.","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"key":"R14-20240220","first-page":"1","article-title":"Racial\/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to opioid treatment programs, 2005\u20132016.","author":"Pouget","year":"2017","journal-title":"Subst Use Misuse"},{"key":"R15-20240220","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.drugalcdep.2015.03.020","article-title":"Racial\/ethnic differences in trends in heroin use and heroin-related risk behaviors among nonmedical prescription opioid users.","volume":"151","author":"Martins","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R16-20240220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/02791072.2016.1259518","article-title":"Racial differences in HIV and HCV risk behaviors, transmission, and prevention knowledge among non-treatment-seeking individuals with opioid use disorder.","volume":"49","author":"Metz","year":"2017","journal-title":"J Psychoactive Drugs"},{"issue":"189","key":"R17-20240220","first-page":"1","article-title":"Prescription opioid analgesic use among adults: United States, 1999\u20132012.","author":"Frenk","year":"2015","journal-title":"NCHS Data Brief"},{"key":"R18-20240220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the united states.","volume":"372","author":"Dart","year":"2015","journal-title":"N Engl J Med"},{"issue":"50\u201351","key":"R19-20240220","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths--United States, 2000\u20132014.","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R22-20240220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.paf.0000114041.70865.24","article-title":"National Association of Medical Examiners Position Paper on the Certification of Cocaine-Related Deaths.","volume":"25","author":"Stephens","year":"2004","journal-title":"Am J Forensic Med Pathol"},{"issue":"6","key":"R26-20240220","first-page":"1","article-title":"Direct standardization (age-adjusted death rates).","author":"Curtin","year":"1995","journal-title":"Heal People 2000 Stat Notes"},{"key":"R27-20240220","first-page":"309","article-title":"3. Sampling variance of standardized mortality rates.","volume":"38","author":"Keyfitz","year":"1966","journal-title":"Hum Biol"},{"key":"R28-20240220","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0021-9681(84)90028-6","article-title":"Approximate variance formulas for standardized rate ratios.","volume":"37","author":"Flanders","year":"1984","journal-title":"J Chronic Dis"},{"key":"R30-20240220","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R31-20240220","first-page":"879","article-title":"Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region\u2014United States, 2006\u20132015.","volume":"66","author":"O\u2019Donnel","year":"2017","journal-title":"MMWR Morb Mort Wkly Rep"},{"key":"R34-20240220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addbeh.2017.05.030","article-title":"Increased use of heroin as an initiating opioid of abuse.","volume":"74","author":"Cicero","year":"2017","journal-title":"Addict Behav"},{"key":"R37-20240220","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.2017.14567","article-title":"Ten steps the federal government should take now to reverse the opioid addiction epidemic.","volume":"318","author":"Kolodny","year":"2017","journal-title":"JAMA"},{"key":"R38-20240220","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"R39-20240220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.","volume":"158","author":"Coffin","year":"2013","journal-title":"Ann Intern Med"},{"key":"R40-20240220","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2105\/AJPH.2015.302638","article-title":"Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration.","volume":"105","author":"Davis","year":"2015","journal-title":"Am J Public Health"},{"key":"R43-20240220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10826080500391795","article-title":"Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies.","volume":"41","author":"Miller","year":"2006","journal-title":"Subst Use Misuse"},{"key":"R44-20240220","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","article-title":"Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study.","volume":"377","author":"Marshall","year":"2011","journal-title":"Lancet"},{"key":"R45-20240220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: what has been demonstrated? A systematic literature review.","volume":"145","author":"Potier","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"R46-20240220","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: no easy fix to its social and economic determinants.","volume":"108","author":"Dasgupta","year":"2018","journal-title":"Am J Public Health"},{"key":"R47-20240220","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2105\/AJPH.2017.304041","article-title":"Despair as a cause of death: more complex than it first appears.","volume":"107","author":"Diez Roux","year":"2017","journal-title":"Am J Public Health"},{"key":"R48-20240220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.amepre.2017.06.009","article-title":"Geographic variation in opioid and heroin involved drug poisoning mortality rates.","volume":"53","author":"Ruhm","year":"2017","journal-title":"Am J Prev Med"},{"issue":"172","key":"R49-20240220","first-page":"1","article-title":"The validity of race and Hispanic-origin reporting on death certificates in the United States: an update.","author":"Arias","year":"2016","journal-title":"Vital Heal Stat 2"},{"key":"R50-20240220","first-page":"1","article-title":"Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates.","volume":"49","author":"Anderson","year":"2001","journal-title":"Natl Vital Stat Rep"},{"key":"R51-20240220","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2017.05.051","article-title":"Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance.","volume":"46","author":"Slavova","year":"2017","journal-title":"Int J Drug Policy"}],"container-title":["Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00001648-201809000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T12:03:53Z","timestamp":1708430633000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001648-201809000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ede.0000000000000858","relation":{"has-preprint":[{"id-type":"doi","id":"10.31235\/osf.io\/jm38s","asserted-by":"object"}]},"ISSN":["1044-3983"],"issn-type":[{"value":"1044-3983","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}